These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 30279372)
1. Assay Challenges for Emerging Infectious Diseases: The Zika Experience. Roberts CC; Maslow JN Vaccines (Basel); 2018 Oct; 6(4):. PubMed ID: 30279372 [TBL] [Abstract][Full Text] [Related]
2. Emerging infectious disease laboratory and diagnostic preparedness to accelerate vaccine development. Roberts CC Hum Vaccin Immunother; 2019; 15(10):2258-2263. PubMed ID: 31268394 [TBL] [Abstract][Full Text] [Related]
3. Serologic Tools and Strategies to Support Intervention Trials to Combat Zika Virus Infection and Disease. Collins MH Trop Med Infect Dis; 2019 Apr; 4(2):. PubMed ID: 31010134 [TBL] [Abstract][Full Text] [Related]
4. Vaccines for emerging infectious diseases: Lessons from MERS coronavirus and Zika virus. Maslow JN Hum Vaccin Immunother; 2017 Dec; 13(12):2918-2930. PubMed ID: 28846484 [TBL] [Abstract][Full Text] [Related]
5. Development of Virus-Like-Particle Vaccine and Reporter Assay for Zika Virus. Garg H; Sedano M; Plata G; Punke EB; Joshi A J Virol; 2017 Oct; 91(20):. PubMed ID: 28794019 [TBL] [Abstract][Full Text] [Related]
6. Identification of Anti-Premembrane Antibody as a Serocomplex-Specific Marker To Discriminate Zika, Dengue, and West Nile Virus Infections. Hsieh SC; Tsai WY; Tsai JJ; Stone M; Simmons G; Busch MP; Lanteri M; Stramer SL; Balmaseda A; Harris E; Wang WK J Virol; 2021 Sep; 95(19):e0061921. PubMed ID: 34232731 [TBL] [Abstract][Full Text] [Related]
7. Rapid response to an emerging infectious disease - Lessons learned from development of a synthetic DNA vaccine targeting Zika virus. Kudchodkar SB; Choi H; Reuschel EL; Esquivel R; Jin-Ah Kwon J; Jeong M; Maslow JN; Reed CC; White S; Kim JJ; Kobinger GP; Tebas P; Weiner DB; Muthumani K Microbes Infect; 2018 Dec; 20(11-12):676-684. PubMed ID: 29555345 [TBL] [Abstract][Full Text] [Related]
8. Mapping time use in clinical trials for vaccines against emerging infectious diseases. Mandi H; Yimer SA; Norheim G Clin Trials; 2021 Jun; 18(3):286-294. PubMed ID: 33653146 [TBL] [Abstract][Full Text] [Related]
11. Zika virus: An emerging infectious disease with serious perinatal and neurologic complications. Casale TB; Teng MN; Morano JP; Unnasch T; Lockwood CJ J Allergy Clin Immunol; 2018 Feb; 141(2):482-490. PubMed ID: 29273403 [TBL] [Abstract][Full Text] [Related]
12. Use of the immunoglobulin G avidity assay to differentiate between recent Zika and past dengue virus infections. Furuya AKM; Hunt D; George KS; Dupuis AP; Kramer LD; Shi PY; Wong S Clin Sci (Lond); 2019 Apr; 133(7):859-867. PubMed ID: 30902827 [TBL] [Abstract][Full Text] [Related]
13. A Glimmer of Hope: Recent Updates and Future Challenges in Zika Vaccine Development. Castanha PMS; Marques ETA Viruses; 2020 Nov; 12(12):. PubMed ID: 33266129 [TBL] [Abstract][Full Text] [Related]